摘要
The N-methyl-d-aspartate(NMDA)receptors,which belong to the ionotropic Glutamate receptors,constitute a family of ligand-gated ion channels.Within the various subtypes of NMDA receptors,the GluN1/2A subtype plays a significant role in central nervous system(CNS)disorders.The present article aims to provide a comprehensive review of ligands targeting GluN2A-containing NMDA receptors,encompassing negative allosteric modulators(NAMs),positive allosteric modulators(PAMs)and competitive antagonists.Moreover,the ligands’structure–activity relationships(SARs)and the binding models of representative ligands are also discussed,providing valuable insights for the clinical rational design of effective drugs targeting CNS diseases.
基金
The work was supported by the National Natural Science Foundation of China(82204200)
the International Postdoctoral Exchange Fellowship Program(Talent-Introduction Program,YJ20210279,China)
the China Postdoctoral Science Foundation(2022M711939)
to Fabao Zhao,and the Natural Science Foundation of Shandong Province(ZR2022QH287 to Fabao Zhao and ZR2022QH312 to Na Liu,China).
